[Form 3] AMDOCS LTD Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Amdocs Ltd officer Matthew E. Smith filed an initial ownership report showing a mix of stock options and ordinary shares. He holds options over 2,683 Ordinary Shares at an exercise price of 55.8800 expiring on February 1, 2029, 3,127 shares at 71.9500 expiring on February 1, 2030, and 925 shares at 67.4600 expiring on June 1, 2028. The filing also lists 2,014 Ordinary Shares held directly, including shares subject to outstanding restricted stock awards. The options vest in equal annual installments over four years from their grant dates.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Smith Matthew E.

Role See Remarks

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 2,683 shares (Direct); Ordinary Shares — 2,014 shares (Direct)

Footnotes (1)

1. The number of shares reported includes Ordinary Shares subject to outstanding restricted stock awards. The options vest in equal annual installments over four years from the grant date.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Smith Matthew E.

(Last) (First) (Middle)

C/O AMDOCS INC

631 MARYVILLE CENTRE DRIVE, SUITE 200

(Street)

SAINT LOUIS MISSOURI 63141

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
AMDOCS LTD [ DOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	2,014(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	02/01/2029	Ordinary Shares	2,683	$55.88	D
Stock Option (Right to Buy)	(2)	02/01/2030	Ordinary Shares	3,127	$71.95	D
Stock Option (Right to Buy)	(2)	06/01/2028	Ordinary Shares	925	$67.46	D

Explanation of Responses:

1. The number of shares reported includes Ordinary Shares subject to outstanding restricted stock awards.

2. The options vest in equal annual installments over four years from the grant date.

Remarks:

Secretary, Head of Investor Relations

	/s/ Smith Matthew	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Amdocs (DOX) Form 3 filing for Matthew E. Smith show?

The Form 3 shows Matthew E. Smith’s initial beneficial ownership in Amdocs. It lists several stock option grants over Ordinary Shares plus directly held Ordinary Shares, establishing his equity position as an officer at the time of becoming a reporting person.

How many Amdocs (DOX) stock options does Matthew E. Smith hold?

Matthew E. Smith holds three stock option grants over Amdocs Ordinary Shares. They cover 2,683 shares at 55.8800, 3,127 shares at 71.9500, and 925 shares at 67.4600, each with its own expiration date between 2028 and 2030.

What Amdocs (DOX) ordinary share holdings are reported for Matthew E. Smith?

The filing reports 2,014 Amdocs Ordinary Shares held directly by Matthew E. Smith. According to a footnote, this number includes Ordinary Shares that are subject to outstanding restricted stock awards, so some portion may still be vesting over time.

How do Matthew E. Smith’s Amdocs (DOX) stock options vest?

The options reported for Matthew E. Smith vest in equal annual installments over four years from their respective grant dates. This means his right to exercise each option grant increases gradually each year, aligning long-term incentives with Amdocs’ performance.

When do Matthew E. Smith’s Amdocs (DOX) stock options expire?

The reported stock options have staggered expiration dates. One grant expires on June 1, 2028, another on February 1, 2029, and the third on February 1, 2030. After these dates, any unexercised options from each grant will lapse.

Is the Amdocs (DOX) Form 3 for Matthew E. Smith a buy or sell transaction?

The Form 3 is not a buy or sell report. It is an initial statement of beneficial ownership that lists Matthew E. Smith’s existing stock options and Ordinary Shares when he became a reporting officer, without indicating any new purchase or sale activity.